In an interview with HIT Consultant, Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA talks how unlocking artificial intelligence (AI) in drug repurposing is transforming pharma and biotech companies.
What are some of the challenges and problems associated with drug discovery “from scratch”?
Nathan Sommerford, Global Lead for Drug Discovery and Development, IQVIA: In the traditional drug discovery and development paradigm, it can cost up to $1.8 billion and
Read More
Most Popular
5 Executives Weigh in on VBC Impact on Kaiser/Geisinger Deal
We recently asked five digital health executives to share their insights on the recent Kaiser's recent acquisition of Geisinger Health and it's impact to accelerate value-based care.
Andy Flanagan, CEO of Iris Telehealth
This acquisition presents a significant upside for the industry's move to improve access to quality, affordable care. Kaiser and Geisinger are two of the premier organizations in our country driving towards value-based care at scale for their communities. The creation
Read More
Digital Health Executive Hires & Departures: Ed Marx Departure, Particle Health CEO, Rhapsody CFO, Others
Health IT veteran Ed Marx announces his departure as CEO at Divurgent to launch his advisory company, Marx Advisory focused on helping healthcare executives & organizations achieve objectives and key results.
Particle Health appointed Jason Prestinario as its next CEO, effective today. Troy Bannister, founder and current CEO, will continue with Particle as Chief Strategy Officer, where he will spearhead product innovation.
Rhapsody names Jeff Chiumiento as the company’s new
Read More
Catalyst by Wellstar Launches $100M Digital Health Venture Fund
What You Should Know:
Catalyst by Wellstar, an innovation company and venture firm created by one of the largest health systems in Georgia launches a $100M digital health venture fund to shape the future of healthcare by creating better care and market value.The venture fund aims to make more than 50 direct investments in early-stage digital health startups, Pre-seed to Series A, over the next five years and invest indirectly in 150+ startups through limited partner investments with venture
Read More
M&A: MultiPlan Acquires Benefits Science LLC for $160M
What You Should Know:
MultiPlan, a provider of data-enabled cost management, payment, and revenue integrity solutions for 700+ healthcare payors announced the acquisition of Benefits Science LLC (BST) for $160M in cash and stock.BST was founded in 2012 by a group of MIT-trained experts in data science, including Dimitris Bertsimas, Ph.D., who is recognized as an early pioneer in healthcare analytics and who serves as the company’s chief data scientist. Dr. Bertsimas will continue with BST
Read More
Q/A: CalmWave CEO Talks Leveraging AI to Reduce Alarm Fatigue
What You Should Know:
Healthcare providers face the difficult challenge of coping with an ever-increasing workload while still providing high-quality patient care and trying to retain their staff. As the CEO of CalmWave, Inc., Ophir Ronen is an expert in both patient outcomes and staff retention who understands the importance of leveraging AI technologies to reduce alarm fatigue and deliver more efficient quiet care.
Delivering Efficient Care by Reducing Alarm Fatigue
Alarm fatigue is
Read More
Elevating Workplace Safety to Combat Healthcare Violence Against Workers
The healthcare workforce is in crisis. From devastating staffing shortages to unmanageable levels of stress and burnout, today’s healthcare workers are desperate for some relief. Unfortunately, exacerbating these already significant challenges is an increasing rate of workplace violence in healthcare.
According to the results of a study published recently in the American Journal of Preventive Medicine, about one-third of public healthcare workers have experienced at least one incident
Read More
Quest Diagnostics Acquires Haystack Oncology for $300M in Cash
What You Should Know:
Quest Diagnostics has reached an agreement to acquire Haystack Oncology an early-stage oncology company focused on minimal residual disease (MRD) testing to aid in the early, accurate detection of residual or recurring cancer and better inform therapy decisionsUnder the terms of the agreement, Quest will pay $300 million in cash at closing, net of cash acquired, and up to an additional $150 million on achieving future performance
Read More
5 Digital Health Executives Share Their Key Takeaways from HIMSS23
John Erwin, CEO of Carenet Health
I was pleased with the robust turnout at HIMSS this year; it does seem like the healthcare industry is making up for the lost time from the pandemic. The topics that dominated the conference included teasing out the nuanced approach to safely deploying Chat GPT/AI into the industry (and when not to), health equity, and the patient journey. Workforce burnout continues to be a major issue in healthcare, though I think we could have
Read More
M&A: Kaiser Acquires Geisinger, Forms Risant Health
What You Should Know:
Kaiser Foundation Hospitals and Geisinger Health are teaming up to launch Risant Health and a definitive agreement to make Geisinger the first health system to join Risant Health to expand access to value-based care in more communities across the country. Upon regulatory approval, Geisinger becomes part of the new organization through acquisition.Risant Health is a new nonprofit organization, created by Kaiser Foundation Hospitals, to expand and accelerate
Read More
